BACKGROUND: The influence of smoking on the natural history of HPV infection in men is not well understood. Smoking could influence the incidence and persistence of HPV infections by suppressing local immune function, increased cellular proliferation, upregulated proinflammatory factors, or induced host DNA damage resulting in increased susceptibility to infection. The purpose of this analysis is to assess prevalent HPV infections by smoking status in men, and to determine baseline risk of HPV infection associated with smoking. METHODS: The HPV in Men (HIM) study is a multinational prospective study of the natural history of HPV infections in men. Samples from the coronal sulcus, glans penis, shaft, and scrotum were combined for HPV DNA testing. Multivariable logistic regression was used to assess the association between smoking and any-, oncogenic-, and nononcogenic HPV infections. RESULTS: Our analyses revealed that current smoking was associated with an increased risk of any HPV infection (OR = 1.19; 95% CI: 1.01-1.41) and oncogenic HPV infection (OR = 1.24; 95% CI: 1.05-1.47). However, the association between smoking and any HPV infection (OR = 1.35; 95% CI: 1.05-1.73) and oncogenic HPV infection (OR = 1.46; 95% CI: 1.11-1.92) was only evident among men reporting fewer lifetime sexual partners. DISCUSSION: These results suggest that current smokers with the fewest number of sexual partners are associated with an increased risk for oncogenic HPV infection. IMPACT: The relationship between smoking and HPV infection remains understudied in men; these data shed new light on the interplay between smoking, sexual activity, and risk of HPV infection.
BACKGROUND: The influence of smoking on the natural history of HPV infection in men is not well understood. Smoking could influence the incidence and persistence of HPV infections by suppressing local immune function, increased cellular proliferation, upregulated proinflammatory factors, or induced host DNA damage resulting in increased susceptibility to infection. The purpose of this analysis is to assess prevalent HPV infections by smoking status in men, and to determine baseline risk of HPV infection associated with smoking. METHODS: The HPV in Men (HIM) study is a multinational prospective study of the natural history of HPV infections in men. Samples from the coronal sulcus, glans penis, shaft, and scrotum were combined for HPV DNA testing. Multivariable logistic regression was used to assess the association between smoking and any-, oncogenic-, and nononcogenic HPV infections. RESULTS: Our analyses revealed that current smoking was associated with an increased risk of any HPV infection (OR = 1.19; 95% CI: 1.01-1.41) and oncogenic HPV infection (OR = 1.24; 95% CI: 1.05-1.47). However, the association between smoking and any HPV infection (OR = 1.35; 95% CI: 1.05-1.73) and oncogenic HPV infection (OR = 1.46; 95% CI: 1.11-1.92) was only evident among men reporting fewer lifetime sexual partners. DISCUSSION: These results suggest that current smokers with the fewest number of sexual partners are associated with an increased risk for oncogenic HPV infection. IMPACT: The relationship between smoking and HPV infection remains understudied in men; these data shed new light on the interplay between smoking, sexual activity, and risk of HPV infection.
Authors: John W Sellors; Tina L Karwalajtys; Janusz Kaczorowski; James B Mahony; Alice Lytwyn; Sylvia Chong; Joanna Sparrow; Attila Lorincz Journal: CMAJ Date: 2003-02-18 Impact factor: 8.262
Authors: Tiffany G Harris; Shalini L Kulasingam; Nancy B Kiviat; Constance Mao; S Nicholas Agoff; Qinghua Feng; Laura A Koutsky Journal: Am J Epidemiol Date: 2004-05-01 Impact factor: 4.897
Authors: Rachel L Winer; Shu-Kuang Lee; James P Hughes; Diane E Adam; Nancy B Kiviat; Laura A Koutsky Journal: Am J Epidemiol Date: 2003-02-01 Impact factor: 4.897
Authors: Howard Minkoff; Joseph G Feldman; Howard D Strickler; D Heather Watts; Melanie C Bacon; Alexandra Levine; Joel M Palefsky; Robert Burk; Mardge H Cohen; Kathryn Anastos Journal: J Infect Dis Date: 2004-04-27 Impact factor: 5.226
Authors: Zhiyue Liu; Alan G Nyitray; Lu-Yu Hwang; Michael D Swartz; Martha Abrahamsen; Eduardo Lazcano-Ponce; Jorge Salmerón; Manuel Quiterio; Luisa L Villa; Maria Luiza Baggio; Roberto J C Silva; Anna R Giuliano Journal: J Infect Dis Date: 2016-08-03 Impact factor: 5.226
Authors: Zhiyue Liu; Alan G Nyitray; Lu-Yu Hwang; Michael D Swartz; Martha Abrahamsen; Eduardo Lazcano-Ponce; Luisa L Villa; Anna R Giuliano Journal: J Infect Dis Date: 2018-02-14 Impact factor: 5.226
Authors: Matthew B Schabath; Zachary J Thompson; Kathleen M Egan; B Nelson Torres; Anthony Nguyen; Mary R Papenfuss; Martha E Abrahamsen; Anna R Giuliano Journal: Sex Transm Infect Date: 2014-10-02 Impact factor: 3.519
Authors: Paula F Blatyta; Shannon Kelly; Ester Sabino; Liliana Preiss; Franciane Mendes; Anna B Carneiro-Proietti; Daniela de Oliveira Werneck Rodrigues; Rosimere Mota; Paula Loureiro; Claudia Maximo; Miriam Park; Alfredo Mendrone-Jr; Thelma T Gonçalez; Cesar de Almeida Neto; Brian Custer Journal: Transfusion Date: 2019-12-05 Impact factor: 3.157
Authors: Anna R Giuliano; Belinda Nedjai; Attila T Lorincz; Michael J Schell; Shams Rahman; Rawinder Banwait; David Boulware; Bradley Sirak; Laura Martin-Gomez; Martha Abrahamsen; Kimberly A Isaacs-Soriano; Bruce Wenig; Christine H Chung; Jimmy Caudell Journal: Int J Cancer Date: 2019-07-26 Impact factor: 7.396
Authors: Frederico O Gleber-Netto; Mei Zhao; Sanchit Trivedi; Jiping Wang; Samar Jasser; Christina McDowell; Humam Kadara; Jiexin Zhang; Jing Wang; William N William; J Jack Lee; Minh Ly Nguyen; Sara I Pai; Heather M Walline; Dong M Shin; Robert L Ferris; Thomas E Carey; Jeffrey N Myers; Curtis R Pickering Journal: Cancer Date: 2017-10-20 Impact factor: 6.860
Authors: Matthew B Schabath; Luisa L Villa; Hui-Yi Lin; William J Fulp; Eduardo Lazcano-Ponce; Jorge Salmerón; Martha E Abrahamsen; Mary R Papenfuss; Manuel Quiterio; Anna R Giuliano Journal: Int J Cancer Date: 2013-11-13 Impact factor: 7.396
Authors: Anna-Barbara Moscicki; Mark Schiffman; Ann Burchell; Ginesa Albero; Anna R Giuliano; Marc T Goodman; Susanne K Kjaer; Joel Palefsky Journal: Vaccine Date: 2012-11-20 Impact factor: 3.641